Skip to main content
Vivo Bio tech Ltd. logo

Vivo Bio tech Ltd. — Investor Relations & Filings

Ticker · 511509 ISIN · INE380K01017 LEI · 98450079E4M2CR80D882 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 440 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS 511509

About Vivo Bio tech Ltd.

http://www.vivobio.com/

Vivo Bio Tech Ltd. is a preclinical Contract Research Organization (CRO) providing comprehensive drug discovery and development services. The company specializes in conducting in vivo preclinical studies, including toxicology, pharmacology, and pharmacokinetic evaluations. It operates advanced facilities for the breeding and distribution of Specific Pathogen Free (SPF) laboratory animal models, maintained through strategic partnerships with global leaders like Taconic Biosciences. Vivo Bio Tech offers regulatory-compliant services such as safety assessment, efficacy testing, and specialized research models to support pharmaceutical and biotechnology sectors. Its operations are characterized by adherence to Good Laboratory Practice (GLP) standards and AAALAC accreditation, ensuring high-quality data for global regulatory submissions.

Recent filings

Filing Released Lang Actions
Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider and approve the ....
Regulatory Filings Classification · 82% confidence The document is an intimation of the date of a Board of Directors meeting under SEBI LODR Regulation 29. It does not present financial results or substantive content itself but merely notifies the company’s regulator and exchange of the meeting date and agenda. It is not a full annual or interim report, nor an earnings release, call transcript, or change in management. Therefore it falls under the general regulatory announcements category (fallback).
2026-05-25 English
please find enclosed
Regulatory Filings Classification · 92% confidence The document is an Annual Secretarial Compliance Report prepared by an external Company Secretary in Practice under SEBI LODR Regulation 24A. It is a statutory compliance certificate and attestation rather than a financial performance report or investor presentation. Per the certification rule, officer certifications and compliance confirmations fall under Regulatory Filings (RNS), not a substantive financial report category.
2026-05-19 English
please find enclosed
Regulatory Filings Classification · 85% confidence The document is a notice to the stock exchange forwarding a compliance report received from the Registrar and Share Transfer Agent regarding re-lodgement of transfer requests for physical shares as required under a SEBI circular. It is not an AGM presentation, financial report, earnings release, capital issuance, shareholding disclosure, M&A, dividend notice, or any other more specific category. It is a general regulatory compliance filing and thus falls under Regulatory Filings (RNS).
2026-05-11 English
please find enclosed
Regulatory Filings
2026-04-13 English
please find enclosed
Regulatory Filings
2026-04-07 English
please find enclosed
Regulatory Filings
2026-04-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.